Pfizer (PFE) Tops Q1 EPS by 24c; offers guidance

Pfizer (NYSE: PFE) reported Q1 EPS of $0.92, $0.24 better than the analyst estimate of $0.68. Revenue for the quarter came in at $13.72 billion versus the consensus estimate of $14.09 billion.

GUIDANCE:

Pfizer sees FY2025 EPS of $2.80-$3.00, versus the consensus of $2.95. Pfizer sees FY2025 revenue of $61-64 billion, versus the consensus of $62.92 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c